FDA Inspection 1287088 — Hill Dermaceuticals, Inc.

Hill Dermaceuticals, Inc. — FEI 1036365

The FDA completed an inspection of Hill Dermaceuticals, Inc. on October 14, 2025 in Sanford, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 14, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sanford, FL (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
22921FDCA 582(b)(4)Systems in place to comply with verification requirements
23276FDCA 582(g)(1)(C)Enhanced systems - verification
356521 CFR 211.58Buildings not maintained in good state of repair
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action